5 hours Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Lag EstimatesZacks
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -3.01% and 0.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
X